|
Live In Play®
Updated: 06-Jul-21 06:05 ET CYDY:
CytoDyn granted a significant patent by USPTO for methods of treating coronavirus infection with Leronlimab
(1.70)
The Patent is owned by CytoDyn and its term of protection is expected to
extend at least until June 15, 2040. The USPTO prioritized examination of
CytoDyn's patent application, resulting in the grant of this Patent under the
USPTO's COVID-19 Prioritized Examination Pilot Program in just about 1 year.
|
